Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
INVISIO AB ( (SE:IVSO) ) has provided an update.
INVISIO’s 2025 annual report frames the company as well-positioned for continued profitable growth in a defense and public safety communications market that is projected to expand over multiple years. The report highlights historically strong growth and margins, a broad solutions ecosystem spanning personal, in-vehicle and intercom systems, and recent product launches that support its ambition to remain a leading supplier of mission-critical communication gear, underpinning its investment appeal for stakeholders.
The company emphasizes a strategy for profitable growth, detailed financial targets and a solid track record, supported by a governance structure and sustainability agenda that address environmental, social and responsible business conduct. By focusing on improving safety and efficiency for users in extreme environments and tailoring complete systems to different customer segments, INVISIO aims to strengthen its market position and reinforce confidence among investors and end users alike.
The most recent analyst rating on (SE:IVSO) stock is a Buy with a SEK294.00 price target. To see the full list of analyst forecasts on INVISIO AB stock, see the SE:IVSO Stock Forecast page.
More about INVISIO AB
INVISIO AB is a global leader in advanced communication and hearing protection systems for defense and public safety users operating in extreme environments. The company focuses on personal, in-vehicle and intercom communication solutions that enhance safety and operational efficiency, targeting a market expected to experience strong multi-year growth and historically high profitability.
Average Trading Volume: 119,665
Technical Sentiment Signal: Hold
Current Market Cap: SEK12.05B
See more data about IVSO stock on TipRanks’ Stock Analysis page.

